Connie L. Erickson‐Miller

Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist

J.M. Jenkins, Daphne Williams, Yanli Deng et al. · Blood · 2007 · 299 citations

Medicine, Pharmacology, Pharmacotherapy +5

Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia

Pinelopi P. Kapitsinou, Qingdu Liu, Travis L. Unger et al. · Blood · 2010 · 298 citations · Full text

Medicine, Hematology, Physiology +13

Preclinical Activity of Eltrombopag (SB-497115), an Oral, Nonpeptide Thrombopoietin Receptor Agonist

Connie L. Erickson‐Miller, Evelyne Delorme, Shin‐Shay Tian et al. · Stem Cells · 2008 · 286 citations · Full text

Medicine, Hematology, Pharmacology +15

Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonist

Connie L. Erickson‐Miller, Evelyne Delorme, Shin‐Shay Tian et al. · Experimental Hematology · 2005 · 206 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

Endothelial HIF-2 mediates protection and recovery from ischemic kidney injury

Pinelopi P. Kapitsinou, Hideto Sano, Mark Michael et al. · Journal of Clinical Investigation · 2014 · 195 citations · Full text

Medicine, Molecular Biology, Pathobiology +17